Literature DB >> 19305954

Interpretation of pulmonary function test: issues and controversies.

Cristine E Berry1, Robert A Wise.   

Abstract

Pulmonary function testing (PFT) serves many purposes in clinical practice, and in contrast to other laboratory measures, PFT results are often provided with a clinical interpretation. PFT interpretation depends on the clinical context, and multiple challenges influence PFT interpretation. Overall, the goal of PFT interpretation is to distinguish normal from abnormal, and this is affected by the selection of reference standards, as well as the arbitrary albeit not necessarily irrational choice of cut-off values. Controversies regarding PFT analysis may lead to important differences in interpretation. In this article, issues associated with the selection of reference standards are discussed, followed by a review of the controversies related to PFT interpretation in the diagnosis of obstructive ventilatory defect, restrictive ventilatory defect, gas transfer defect, and flow-volume loop abnormalities. Given the challenges facing PFT interpretation, no single interpretative algorithm is sufficient; rather, PFT interpretation requires a comprehensive approach including consideration of the clinical context, laboratory methodology, and reference standards and an understanding of the consequences of a normal or abnormal designation.

Entities:  

Mesh:

Year:  2009        PMID: 19305954     DOI: 10.1007/s12016-009-8123-4

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  36 in total

1.  How accurate is spirometry at predicting restrictive pulmonary impairment?

Authors:  S D Aaron; R E Dales; P Cardinal
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

2.  Reference equations used to predict pulmonary function. Survey at institutions with respiratory disease training programs in the United States and Canada.

Authors:  A J Ghio; R O Crapo; C G Elliott
Journal:  Chest       Date:  1990-02       Impact factor: 9.410

3.  Prediction equations for single breath diffusing capacity (Tlco) in a middle aged caucasian population.

Authors:  B R Thompson; D P Johns; M Bailey; J Raven; E H Walters; M J Abramson
Journal:  Thorax       Date:  2008-04-04       Impact factor: 9.139

4.  Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.

Authors:  Ciro Casanova; Claudia Cote; Juan P de Torres; Armando Aguirre-Jaime; Jose M Marin; Victor Pinto-Plata; Bartolome R Celli
Journal:  Am J Respir Crit Care Med       Date:  2004-12-10       Impact factor: 21.405

5.  Upper airway function in burn patients. Correlation of flow-volume curves and nasopharyngoscopy.

Authors:  E F Haponik; A M Munster; R A Wise; P L Smith; D A Meyers; E J Britt; E R Bleecker
Journal:  Am Rev Respir Dis       Date:  1984-02

6.  Discordance in spirometric interpretations using three commonly used reference equations vs national health and nutrition examination study III.

Authors:  Jacob Collen; David Greenburg; Aaron Holley; Christopher S King; Oleh Hnatiuk
Journal:  Chest       Date:  2008-11       Impact factor: 9.410

7.  Absence of positional change in pulmonary diffusing capacity in systemic sclerosis.

Authors:  W H Ettinger; R A Wise; M B Stevens; F M Wigley
Journal:  Am J Med       Date:  1983-08       Impact factor: 4.965

8.  Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease.

Authors:  Michael B Drummond; Pamela F Schwartz; William T Duggan; John G Teeter; Richard J Riese; Richard C Ahrens; Robert O Crapo; Richard D England; Neil R Macintyre; Robert L Jensen; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2008-05-08       Impact factor: 21.405

9.  Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization.

Authors:  Mary Sau-man Ip; Fanny Wai-san Ko; Arthur Chun-wing Lau; Wai-cho Yu; Kam-shing Tang; Kahlin Choo; Moira Mo-wah Chan-Yeung
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

10.  Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

Authors:  Panagiota I Latsi; Roland M du Bois; Andrew G Nicholson; Thomas V Colby; Danai Bisirtzoglou; Ageliki Nikolakopoulou; Srihari Veeraraghavan; David M Hansell; Athol U Wells
Journal:  Am J Respir Crit Care Med       Date:  2003-06-05       Impact factor: 21.405

View more
  5 in total

1.  Quantitative computerized two-point correlation analysis of lung CT scans correlates with pulmonary function in pulmonary sarcoidosis.

Authors:  Barbaros Selnur Erdal; Elliott D Crouser; Vedat Yildiz; Mark A King; Andrew T Patterson; Michael V Knopp; Bradley D Clymer
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

2.  Overall mortality.

Authors:  Duncan F Moore; Virginia D Steen
Journal:  J Scleroderma Relat Disord       Date:  2020-06-08

3.  Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.

Authors:  Tracy J Doyle; Namrata Dhillon; Rachna Madan; Fernanda Cabral; Elaine A Fletcher; Diane C Koontz; Rohit Aggarwal; Juan C Osorio; Ivan O Rosas; Chester V Oddis; Paul F Dellaripa
Journal:  J Rheumatol       Date:  2018-04-01       Impact factor: 4.666

4.  Muscle metabolomics analysis reveals potential biomarkers of exercise‑dependent improvement of the diaphragm function in chronic obstructive pulmonary disease.

Authors:  Jian Li; Yufan Lu; Ning Li; Peijun Li; Jianqing Su; Zhengrong Wang; Ting Wang; Zhaoyu Yang; Yahui Yang; Haixia Chen; Lu Xiao; Hongxia Duan; Weibing Wu; Xiaodan Liu
Journal:  Int J Mol Med       Date:  2020-03-12       Impact factor: 4.101

5.  Safety and use of pulmonary function tests: a retrospective study from a single center over seven years' clinical practice.

Authors:  Fei Li; Zhi-Wen Huang; Xiao-Fei Wang; Hui-Wen Xu; Hua Yu; Yan-Bin Chen; Jian-An Huang; Jia-Jia Wang; Wei Lei
Journal:  BMC Pulm Med       Date:  2019-12-21       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.